You've been trying. The tests come back "normal" or they don't, and either way the answer is the same — keep waiting, keep spending, keep hoping. Meanwhile the biology is working against a clock nobody can pause.
Fertility treatment escalates in predictable steps: ovulation induction with clomiphene or letrozole, then IUI, then IVF. Success rates vary widely by age and cause. IVF runs $15–25k per cycle with roughly 30–40% success rates under 35, dropping sharply after 40. Male factor infertility gets less attention — lifestyle modification, sometimes varicocele repair, often straight to ICSI. The process is emotionally and financially brutal, and the underlying biology (oxidative stress, poor perfusion, mitochondrial decline) is rarely addressed directly.
Fosen and Thom (2014) reviewed the evidence in Reproductive Sciences showing that HBOT mobilizes stem/progenitor cells from bone marrow and increases circulating stem cells that can home to reproductive tissues, enhancing tissue repair and vascularization — directly relevant to endometrial receptivity and ovarian function.1
Yokoi et al. (2020) published in Reproductive Medicine and Biology a study of women with thin endometrium refractory to conventional treatment. HBOT at 1.4 ATA produced significant increases in endometrial thickness, enabling successful embryo transfer in patients who had previously failed. The mechanism was enhanced angiogenesis and improved uterine blood flow.2
Mitrovic et al. (2006) demonstrated in a study published in Srpski Arhiv za Celokupno Lekarstvo that mild HBOT improved sperm motility and morphology in men with idiopathic infertility, consistent with the role of enhanced oxygenation in reducing oxidative damage to spermatozoa.3
Ohshiro (2012) published a landmark case series in Laser Therapy documenting successful pregnancies in women who had failed repeated IVF cycles after receiving near-infrared photobiomodulation (830 nm) to the abdomen and neck. Of 74 previously infertile women treated, 22.3% achieved pregnancy, with the proposed mechanism being improved ovarian and uterine blood flow.4
Endo et al. (2020) expanded on this work in Laser Therapy, showing that proximal-priority PBM treatment at 830 nm improved oocyte quality and endometrial receptivity in women with diminished ovarian reserve. Near-infrared light enhanced mitochondrial ATP production in granulosa cells, directly improving the cellular energy available for egg maturation.5
Salman Yazdi et al. (2014) demonstrated in Lasers in Medical Science that 830 nm photobiomodulation improved sperm motility and viability in vitro, with treated samples showing significantly better progressive motility than controls. The effect was dose-dependent and mediated by mitochondrial stimulation.6